As Europe's second largest biotechnology market, France offers a market depth that needs to be supported. This premise led Goodwin to recruit Anne-Charlotte Rivière as a partner in Paris in order to form a venture division dedicated to Life Sciences and Technologies. Read the announcement in CF News here.